首页|Peking University Cancer Hospital and Institute Reports Findings in Lymphoma (De velopment and validation of a hierarchical approach for lymphoma classification using immunohistochemical markers)
Peking University Cancer Hospital and Institute Reports Findings in Lymphoma (De velopment and validation of a hierarchical approach for lymphoma classification using immunohistochemical markers)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News-New research on Oncology - Lymphoma is the subject of a report. According tonews reporting originating in Beijing, Pe ople's Republic of China, by NewsRx journalists, research stated,"Accurate lymp homa classification is critical for effective treatment and immunohistochemistry is a costeffectiveand time-saving approach. Although several machine learning algorithms showed effective results,they focused on a specific task of classif ication but not the whole classification workflow, thus impracticalto be applie d in clinical settings."Financial supporters for this research include National Key Research and Develop ment Program ofChina, National Natural Science Foundation of China.
BeijingPeople's Republic of ChinaAsi aBiomarkersCancerCyborgsDiagnostics and ScreeningEmerging TechnologiesHealth and MedicineHematologyImmunoproliferative DisordersLymphatic Dise ases and ConditionsLymphomaLymphoproliferative DisordersMachine LearningOncology
NETL
NSTL
